The DOI matches its Crossref record; 202 of the 206 references it cites were found in a registry or an index.
The effect of HIF on metabolism and immunity
Open accessAbstract
Cellular hypoxia occurs when the demand for sufficient molecular oxygen needed to produce the levels of ATP required to perform physiological functions exceeds the vascular supply, thereby leading to a state of oxygen depletion with the associated risk of bioenergetic crisis. To protect against the threat of hypoxia, eukaryotic cells have evolved the capacity to elicit oxygen-sensitive adaptive transcriptional responses driven primarily (although not exclusively) by the hypoxia-inducible factor (HIF) pathway. In addition to the canonical regulation of HIF by oxygen-dependent hydroxylases, multiple other input signals, including gasotransmitters, non-coding RNAs, histone modifiers and post-translational modifications, modulate the nature of the HIF response in discreet cell types and contexts. Activation of HIF induces various effector pathways that mitigate the effects of hypoxia, including metabolic reprogramming and the production of erythropoietin. Drugs that target the HIF pathway to induce erythropoietin production are now approved for the treatment of chronic kidney disease-related anaemia. However, HIF-dependent changes in cell metabolism also have profound implications for functional responses in innate and adaptive immune cells, and thereby heavily influence immunity and the inflammatory response. Preclinical studies indicate a potential use of HIF therapeutics to treat inflammatory diseases, such as inflammatory bowel disease. Understanding the links between HIF, cellular metabolism and immunity is key to unlocking the full therapeutic potential of drugs that target the HIF pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under hypoxic conditions, where oxygen is unavailable for the hydroxylation reaction, HIF-1α accumulates and forms a dimer with the oxygen-independent ARNT [4].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A central cellular response to hypoxia and HIF activation is metabolic reprogramming to favor energy-generating pathways that do not require oxygen; the best characterized of which, is the switch from oxidative phosphorylation in the mitochondria (a process that utilizes ~90% of available oxygen), to anerobic glycolysis, thus preserving cellular bioenergetics during periods of oxygen deprivation (”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
RetractedSamanta, D., Park, Y., Andrabi, S. A., Shelton, L. M., Gilkes, D. M., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0530 · Cited by 242
RetractedWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Research works printed but not linked: 1
- Wang, T. et al. HIF1α-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediat. Inflamm. 2017, 9029327 (2017).
Cited by
Sorted by citations
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
Bai, R., Li, Y., Jian, L., Yue-hui, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 296
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00848-6 · Cited by 245
Mitochondrial metabolism and cancer therapeutic innovation
Du, H., Xu, T., Yu, S., Wu, S., & Zhang, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02311-x · Cited by 283
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
Liu, B., Xian, Y., Chen, X. '., Shi, Y., Dong, J., Yang, L., An, X., Shen, T., Wu, W., Ma, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307338 · Cited by 152
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
Guo, Y., Hu, P., & Shi, J. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c14005 · Cited by 136
Huang, H., Li, G., He, Y., Chen, J., Yan, J., Zhang, Q., Li, L., & Cai, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404441 · Cited by 155
Zhang, H., Wu, D., Wang, Y., Guo, K., Spencer, C. B., Ortoga, L., Qu, M., Shi, Y., Shao, Y., Wang, Z., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1389 · Cited by 131
Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome
Gao, Y., Zou, Y., Wu, G., & Zheng, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1193749 · Cited by 128
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Why cells need iron: a compendium of iron utilisation
Teh, M. R., Armitage, A. E., & Drakesmith, H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.04.015 · Cited by 114
Linke, J. A., Munn, L. L., & Jain, R. K. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00745-z · Cited by 109
Mechanisms underlying the health benefits of intermittent hypoxia conditioning
Burtscher, J., Citherlet, T., Camacho-Cardeñosa, A., Camacho-Cardeñosa, M., Raberin, A., Krumm, B., Hohenauer, E., Egg, M., Lichtblau, M., Müller, J., et al. (2023) · The Journal of Physiology · doi:10.1113/jp285230 · Cited by 132
Shen, X., Pan, D., Gong, Q., Gu, Z., & Luo, K. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.017 · Cited by 96
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Qin, Y., Han, S., Yu, Y., Ding, Q., Ran, M., Yang, M., Liu, Y., Li, Y., Lu, L., Liu, Y., et al. (2024) · Liver International · doi:10.1111/liv.15953 · Cited by 100
Lian, C., Liu, J., Wei, W., Wu, X., Goto, T., Li, H., Tu, R., & Dai, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.028 · Cited by 94
Ovarian aging: energy metabolism of oocytes
Bao, S., Yin, T., & Liu, S. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01427-y · Cited by 92
The Interplay between Immune and Metabolic Pathways in Kidney Disease
Jiao, B., & Qu, L. (2023) · Cells · doi:10.3390/cells12121584 · Cited by 89
ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
Chen, Y.-S., Tian, H., Rong, D., Wang, L., Chen, S., Zeng, J., Xu, H., Mei, J., Wang, L.-Y., Liou, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00338-8 · Cited by 96
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
Li, H., Zandberg, D. P., Kulkarni, A., Chiosea, S. I., Santos, P. M., Isett, B. R., Joy, M., Sica, G., Contrera, K. J., Tatsuoka, C. M., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.026 · Cited by 85
Wang, W., Yao, S., Luo, J., Ding, C., Huang, Q., Yang, Y., Shi, Z., Lin, J., Pan, Y., Zeng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55905-y · Cited by 92
Raslan, A., Pham, T. X., Lee, J., Kontodimas, K., Tilston-Lünel, A., Schmottlach, J., Hong, J., Dinc, M. T., Bujor, A. M., Caporarello, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49545-x · Cited by 84
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression
Jomová, K., Alomar, S. Y., Valko, R., Fresser, L., Nepovimová, E., Kuča, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04146-5 · Cited by 103
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 93
Living in a hypoxic world: A review of the impacts of hypoxia on aquaculture
Zhan, Y., Ning, B., Sun, J., & Chang, Y. (2023) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2023.115207 · Cited by 75
Madai, S., Kilic, P., Schmidt, R. M., Orth, C. B., Korff, T., Büttner, M., Klinke, G., Poschet, G., Marti, H. H., & Kunze, R. (2024) · Theranostics · doi:10.7150/thno.88223 · Cited by 72
Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm
Wang, Y., Ge, M., Wang, J., Xu, Y., Wang, N., & Xu, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08114-w · Cited by 83
How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia
Mirchandani, A. S., Sánchez-García, M. A., & Walmsley, S. R. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01087-5 · Cited by 77
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Ciepła, J., & Smolarczyk, R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01501-1 · Cited by 81
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Yang, X., Guo, H., & Zou, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00395-z · Cited by 85
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Ortmann, B. M. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000154 · Cited by 67
Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration
Song, C., Hu, P., Peng, R., Li, F., Fang, Z., & Xu, Y. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107119 · Cited by 69
Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms
Tasouli-Drakou, V., Ogurek, I., Shaikh, T., Ringor, M., Dicaro, M. V., & Lei, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031364 · Cited by 79
Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis
Matsuoka, K., Bakiri, L., Bilban, M., Toegel, S., Haschemi, A., Yuan, H., Kasper, M., Windhager, R. H., & Wagner, E. F. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224002 · Cited by 65
Chae, S. Y., Kim, Y., & Park, C. W. (2023) · Antioxidants · doi:10.3390/antiox12122083 · Cited by 65
Hypoxia-Inducible Factor 1-Alpha (HIF-1α): An Essential Regulator in Cellular Metabolic Control
Basheeruddin, M., & Qausain, S. (2024) · Cureus · doi:10.7759/cureus.63852 · Cited by 69
Integrating bioelectronics with cell-based synthetic biology
Rivnay, J., Raman, R., Robinson, J. T., Schreib, C. C., Cohen‐Karni, T., Galloway, K. E., & Omid Veiseh, A. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00262-6 · Cited by 61
Metabolic alterations in hereditary and sporadic renal cell carcinoma
Coffey, N. J., & Simon, M. C. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00800-2 · Cited by 56
Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy
Yu, J., Wu, J., Huang, J., Xu, C., Xu, M., Koh, C. Z. H., Pu, K., & Zhang, Y. (2025) · Nature Communications · doi:10.1038/s41467-024-55529-8 · Cited by 52
Khouzam, R. A., Janji, B., Thiery, J., Zaarour, R. F., Chamseddine, A. N., Mayr, H., Savagner, P., Kiéda, C., Gad, S., Buart, S., et al. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.008 · Cited by 54
Li, H., Ouyang, Y., Lv, H., Liang, H., Luo, S., Zhang, Y., Mao, H., Chen, T., Chen, W., Zhou, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122926 · Cited by 50
Vitamin C: From nutrition to oxygen sensing and epigenetics
Kietzmann, T. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102753 · Cited by 57
Kupffer cell programming by maternal obesity triggers fatty liver disease
Huang, H., Balzer, N. R., Seep, L., Šplíchalová, I., Blank-Stein, N., Viola, M. F., Taveras, E. F., Acil, K., Fink, D., Petrovic, F., et al. (2025) · Nature · doi:10.1038/s41586-025-09190-w · Cited by 52
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
Viel, S., Vivier, É., Walzer, T., & Marçais, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01098-w · Cited by 53
Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition
Li, C., Fu, C., Zhou, W., Li, H., Liu, Z., Wu, G., He, T., Shen, M., & Liu, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02366-x · Cited by 60
The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering
You, J., Liu, M., Li, M., Zhai, S., Quni, S., Zhang, L., Liu, X., Jia, K., Zhang, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098029 · Cited by 52
Redox regulation of cancer stem cells: Biology and therapeutic implications
Du, M., Zhang, J., Wicha, M. S., & Luo, M. (2024) · MedComm – Oncology · doi:10.1002/mog2.70005 · Cited by 45
Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy
Zhang, H., Fan, J., Kong, D., Sun, Y., Zhang, Q., Xiang, R., Lu, S., Yang, W., Feng, L., & Zhang, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02460-1 · Cited by 49
Yao, J., Liu, J., He, Y., Lin, X., Xu, Z., Lin, X., Liu, N., & Kai, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116533 · Cited by 48
Lumpuy‐Castillo, J., Amador‐Martínez, I., Díaz-Rojas, M., Lorenzo, Ó., Pedraza-Chaverrí, J., Sánchez‐Lozada, L. G., & Aparicio‐Trejo, O. E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103340 · Cited by 45
Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis
Steiner, C. A., Cartwright, I. M., Taylor, C. T., & Colgan, S. P. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00227.2022 · Cited by 44
Self-citationThe HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Huang, W., Fu, G., Wang, Y., Chen, C., Luo, Y., Yan, Q., Liu, Y., & Mao, C. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.03.031 · Cited by 44
Darweesh, M. F., Mohammadi, S., Rahmati, M., Al-Hamadani, M., & Al‐Harrasi, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578202 · Cited by 51
Endothelial GLUTs and vascular biology
Wu, W., & Bai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114151 · Cited by 42
Hypoxia signaling in the adipose tissue
Huynh, P. M., Wang, F., & An, Y. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae039 · Cited by 42
Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells
Goldmann, O., & Medina, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1461455 · Cited by 42
Ahuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 43
Immune Cell Migration to Cancer
Ryan, A. T., Kim, M., & Lim, K. (2024) · Cells · doi:10.3390/cells13100844 · Cited by 35
Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection
Roy, Z. A. V., Arumugam, P., Bertrand, B. P., Shinde, D. D., Thomas, V. C., & Kielian, T. (2024) · Nature Communications · doi:10.1038/s41467-024-53353-8 · Cited by 36
Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 32
Han, Z., Fu, J., Gong, A., & Ren, W. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2789-1 · Cited by 33
The regulation of cell metabolism by hypoxia and hypercapnia
Reddan, B., & Cummins, E. P. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108252 · Cited by 34
Immune consequences of exercise in hypoxia: A narrative review
Burtscher, J., Pasha, Q., Chanana, N., Millet, G. P., Burtscher, M., & Strasser, B. (2023) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2023.09.007 · Cited by 34
Hypoxia-Induced Signaling in Gut and Liver Pathobiology
Solanki, S. A., & Shah, Y. M. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-094743 · Cited by 34
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 36
Zhang, Y., Zhang, S., Yang, L., Zhang, Y., Cheng, Y., Jia, P., Lv, Y., Wang, K., Fan, P., Zhang, P., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113801 · Cited by 31
Farsani, S. S. M., & Verma, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1175532 · Cited by 33
Luo, H., Wang, Q., Yang, F., Liu, R. R., Gao, Q., Cheng, B., Lin, X., Huang, L., Chen, C., Jin, X., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164968 · Cited by 39
Photosynthetic and Self‐Draining Biohybrid Dressing for Accelerating Healing of Diabetic Wound
Ren, X., Hou, Z., Pang, B., Gao, C., & Tang, R. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302287 · Cited by 30
p53 in colorectal cancer: from a master player to a privileged therapy target
Yan, S., Zhan, F., He, Y., Zhu, Y., & Ma, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06566-4 · Cited by 33
Reduced adipocyte glutaminase activity promotes energy expenditure and metabolic health
Lecoutre, S., Maqdasy, S., Rizo‐Roca, D., Renzi, G., Vlassakev, I., Alaeddine, L. M., Higos, R., Jalkanen, J., Zhong, J., Zareifi, D., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01083-y · Cited by 33
Xu, J., Wakai, M., Xiong, K., Yang, Y., Prabakaran, A., Wu, S. P., Ahrens, D., Molina‐Portela, M. D. P., Ni, M., Bai, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115403 · Cited by 35
Fang, C., Zeng, Z., Ni, B., Wen, X., Fang, Z., Zou, J., & Zhang, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1681875 · Cited by 29
Role of HIF in fish inflammation
Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 28
Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn’s disease
Ahn, J.-H., Pedrosa, M. D. S., Lopez, L. R., Tibbs, T., Jeyachandran, J. N., Vignieri, E. E., Rothemich, A., Cumming, I., Irmscher, A. D., Haswell, C. J., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.11.012 · Cited by 30
Yue, B., Gao, Y., Hu, Y., Zhan, M., Wu, Y., & Lu, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1731 · Cited by 26
Lu, Z., Li, H., Song, N., Wang, Z.-W., Wang, H., Rehman, A., Han, L., & Zeng, K. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c17885 · Cited by 27
Li, W., Chen, S., Lu, J., Mao, W., Zheng, S., Zhang, M., Wu, T., Chen, Y., Lu, K., Chu, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61560-0 · Cited by 30
Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
Anselme, M., He, H., Lai, C., Luo, W., & Zhong, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06976-4 · Cited by 33
Sønstevold, L., Czerkies, M., Escobedo-Cousin, E., Blonski, S., & Vereshchagina, E. (2023) · Micromachines · doi:10.3390/mi14030532 · Cited by 25
Xu, Q., Kong, H., Ren, S., Meng, F., Liu, R., Jin, H., & Zhang, J. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00833-6 · Cited by 26
Sartor, F., Ferrero‐Bordera, B., Haspel, J. A., Sperandio, M., Holloway, P. M., & Merrow, M. W. (2024) · Circulation Research · doi:10.1161/circresaha.124.323518 · Cited by 26
Cardiac fibrogenesis: an immuno-metabolic perspective
Hoque, M. M., Gbadegoye, J. O., Hassan, F. O., Raafat, A., & Lebeche, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1336551 · Cited by 30
Zhu, X., Yang, C., Yu, Q., & Han, L. (2024) · Meat Science · doi:10.1016/j.meatsci.2024.109692 · Cited by 27
Xiao, Q., Zhang, X., Chen, Z., Zou, Y.-Y., & Tang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010332 · Cited by 28
Zaarour, R. F., Ribeiro, M., Azzarone, B. G., Kapoor, S., & Chouaı̈b, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1222575 · Cited by 25
Liu, X., Tang, J., Wang, Z., Zhu, C., Deng, H., Sun, X., Yu, G., Rong, F., Chen, X., Liao, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47814-3 · Cited by 33
Qi, P., Jiang, X., Wang, X., Sheng, L., Liang, J., & Zhang, L. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00701-1 · Cited by 29
Role of Ischemia/Reperfusion and Oxidative Stress in Shock State
Vázquez-Galán, Y. I., Guzmán-Silahua, S., Trujillo-Rangel, W. Á., & Rodríguez-Lara, S. Q. (2025) · Cells · doi:10.3390/cells14110808 · Cited by 29
Munteanu, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098376 · Cited by 27
Detection, mechanisms, and therapeutic implications of oncometabolites
Cai, Y., Wang, Z., Guo, S., Lin, C., Yao, H., Yang, Q., Wang, Y., Yu, X., He, X., Sun, W., et al. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.018 · Cited by 25
Decoding Allosteric Control in Hypoxia-Inducible Factors
Zhuang, J., Shang, Q., Rastinejad, F., & Wu, D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168352 · Cited by 25
Mitochondrial metabolism regulation and epigenetics in hypoxia
Laird, M., Ku, J. C., Raiten, J., Sriram, S., Moore, M., & Li, Y. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1393232 · Cited by 26
Deng, K., Hua, Y., Gao, Y., Zheng, H., Jiang, Y., Wang, Y., Gao, C., Ren, T., & Zhu, Y. (2024) · Advanced Science · doi:10.1002/advs.202408013 · Cited by 25
Qin, Y., Zhang, Z., Guo, X., Li, W., Xia, W., Ge, G., Li, Y., Guan, M., Gao, A., Mao, L., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202418822 · Cited by 24
Microenvironment of diabetic foot ulcers: Implications for healing and therapeutic strategies
Wang, J., Yang, X., Zhou, T., Ma, H., Yuan, X., Yan, S., & Wang, S. (2025) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_573_24 · Cited by 31
Astroimmunology: the effects of spaceflight and its associated stressors on the immune system
Winer, D. A., Du, H., Kim, J., Chang, V., Burke, M., Winer, S., Costes, S. V., Frippiat, J., Sams, C. F., Paul, A. M., et al. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01226-6 · Cited by 30
Alnahhas, N., Pouliot, É., & Saucier, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1260987 · Cited by 26
Metadata
- Authors
- Taylor, C. T., & Scholz, C. C.
- Affiliations
- University College Dublin (IE)
- University of Zurich (CH)
- Corresponding author
- Taylor, Cormac T.
- Venue
- Nature Reviews Nephrology
- Published
- 2022-06-20
- Volume
- 18
- Issue
- 9
- Pages
- 573-587
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- PMC
- PMC9208707
- OpenAlex
- W4283204847
- Cited by
- 517
- References
- 206
- Citations by year
- 2026: 106 · 2025: 186 · 2024: 143 · 2023: 77 · 2022: 5
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- hypoxia-inducible factor, cellular hypoxia, cellular metabolism, immune cell function, metabolic reprogramming, erythropoietin, gasotransmitters, non-coding RNA, histone modifiers, post-translational modification, inflammatory bowel disease, inflammation, innate and adaptive immunity
- MeSH terms
- Hypoxia, Erythropoietin, Humans, Kidney, Oxygen, Cell Hypoxia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review